Compiled by Cari Kraft, Jacobs Management Group, Inc.
BY THE NUMBERS
Consumers want virtual health
In a survey of more than 1,500 consumers, Accenture found
that consumers are willing to use a wide range of virtual health
services. Interestingly, only 21% have actually tried it.
Source: Accenture Consulting, “Virtual Health: The Untapped
Opportunity to Get the Most out of Healthcare,” 2015
Biotech revenues mixed, generally up
Growth is still the mainstay for biotech, with 70% of
the companies on the list experiencing an increase
in revenue from 2015 and 30% of the companies
experiencing a revenue decline.
Source: Healthcare Sales & Marketing, April/May
2017, “Top 50 Biotech Companies”.
Percent of hospitals that say developing
value-based payment models is a
priority over the next 12-18 months
78% of physician practices are participating
in value-based payment models, and
participation among facilities is 91%. This
includes Medicare quality incentives, pay for
performance, ACOs and bundled payments.
Source: Availity study “Provider Outlook on
Value-based Payment Models,” April 2016
Venture capital device and
biopharma investment in 2016
Venture capital firms invested over
$74B in the device and biopharma
sectors last year. The past two years
saw nearly double the investment
activity compared with 2011-2013.
Source: “Trends in Healthcare
Investments and Exits 2017,” Silicon
Valley Bank, based on PitchBook, NVCA
and SVB proprietary data.